Practical Set-Up

Part of the Medical Radiology book series (MEDRAD)


In performing a cardiovascular MRI examination, preparation is considered to be paramount to a successful subsequent image acquisition. Although seemingly trivial, this image acquisition and interpretation requires a working knowledge of adequate patient preparation, ECG lead placement, breath-hold instructions and contrast injection. This expertise should be accompanied by knowledge of safety issues and precautions in the MRI environment. The purpose of this chapter is to provide MRI users, in particular those who aim to perform cardiovascular MRI studies in daily clinical practice, a practical introduction to setting up and performing an MR scan.The safety issues in the MR suite will be discussed and ample attention is given to the specific patient preparation for patients undergoing cardiac MR. Several contra-indications and risks relating to pregnancy and contrast media will be discussed.


Static Magnetic Field Nephrogenic Systemic Fibrosis Specific Absorption Rate Reed Switch Ferromagnetic Object 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Ahmed S, Shellock FG (2001) Magnetic resonance imaging safety: implications for cardiovascular patients. J Cardiovasc Magn Reson 3:171–182PubMedCrossRefGoogle Scholar
  2. Collins CM, Liu W, Wang J et al (2004) Temperature and SAR calculations for a human head within volume and surface coils at 64 and 300 MHz. J Magn Reson Imaging 19:650–656PubMedCrossRefGoogle Scholar
  3. Farling P, McBrien ME, Winder RJ (2003) Magnetic resonance compatible equipment: read the small print!. Anaesthesia 58:86–87PubMedCrossRefGoogle Scholar
  4. Gimbel JR, Kanal E (2004) Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol 43:1325–1327PubMedCrossRefGoogle Scholar
  5. Greatbatch W, Miller V, Shellock FG (2002) Magnetic resonance safety testing of a newly-developed fiber-optic cardiac pacing lead. J Magn Reson Imaging 16:97–103PubMedCrossRefGoogle Scholar
  6. Grobner T (2006) Gadolinium–a specific trigger for the development of nephrogenic fibro sing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21(4):1104–1108PubMedCrossRefGoogle Scholar
  7. Kanal E (2002) American college of radiology white paper on MR safety. Am J Roentgenol 178:1335–1347Google Scholar
  8. Kanal E (2004) Clinical utility of the American college of radiology MR safe practice guidelines. J Magn Reson Imaging 19:2–5PubMedCrossRefGoogle Scholar
  9. Knudson M (2011) New wave of MRI-safe pacemakers set to ship to hospitals. Scientific American, 16 Feb 2011Google Scholar
  10. Lamireau T, Dubreuil M, Daconceicao M (1998) Oxygen saturation during esophagogastroduodenoscopy in children: general anesthesia versus intravenous sedation. J Pediatr Gastroenterol Nutr 27:172–175PubMedCrossRefGoogle Scholar
  11. Luechinger R, Duru F, Zeijlemaker VA et al (2002) Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 T magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 25:1419–1423PubMedCrossRefGoogle Scholar
  12. Malviya S, Voepel-Lewis T, Eldevik OP et al (2000) Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth 84:743–748PubMedGoogle Scholar
  13. Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362PubMedCrossRefGoogle Scholar
  14. Martin ET, Coman JA, Shellock FG et al (2004) Magnetic resonance imaging and cardiac pacemaker safety at 1.5 T. J Am Coll Cardiol 43:1315–1324PubMedCrossRefGoogle Scholar
  15. Nahrendorf M, Hiller KH, Hu K, Zeijlemaker V et al (2004) Pacing in high field cardiac magnetic resonance imaging. Pacing Clin Electrophysiol 27:671–674PubMedCrossRefGoogle Scholar
  16. Partain CL, Price RR (2004) MR safety. J Magn Reson Imaging 19:1PubMedCrossRefGoogle Scholar
  17. Pohost GM (2001) Editor’s page: is CMR safe? J Cardiovasc Magn Reson 3:9Google Scholar
  18. Shellock FG (2001) Pocket guide to MR procedures and metallic objects. Lippincott, Williams & Wilkins, Philadelphia 0781733537Google Scholar
  19. Shellock FG, Kanal E (1991) Policies, guidelines, and recommendations for MR imaging safety and patient management. SMRI safety committee. J Magn Reson Imaging 1:97–101PubMedCrossRefGoogle Scholar
  20. Shellock FG, Tkach JA, Ruggieri PM et al (2003) Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional (“long-bore”) and “short-bore” 1.5 and 3.0 T MR systems. J Cardiovasc Magn Reson 5:387–397PubMedCrossRefGoogle Scholar
  21. Sommer T, Vahlhaus C, Lauck G et al (2000) MR imaging and cardiac pacemakers: in vitro evaluation and in vivo studies in 51 patients at 0.5 T. Radiology 215:869–879PubMedGoogle Scholar
  22. Thomsen HS (2009) Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin North Am 47(5):827–831PubMedCrossRefGoogle Scholar
  23. Webb JAW, Thomsen HS, Morcos SK (2005) Members of contrast media safety committee of European society of urogenital radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15:1234–1240PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.Department of RadiologyUniversity Hospitals Gasthuisberg, Catholic University of LeuvenLeuvenBelgium

Personalised recommendations